AU3827199A - Use of antioxidants for the treatment of inflammatory skin diseases - Google Patents

Use of antioxidants for the treatment of inflammatory skin diseases

Info

Publication number
AU3827199A
AU3827199A AU38271/99A AU3827199A AU3827199A AU 3827199 A AU3827199 A AU 3827199A AU 38271/99 A AU38271/99 A AU 38271/99A AU 3827199 A AU3827199 A AU 3827199A AU 3827199 A AU3827199 A AU 3827199A
Authority
AU
Australia
Prior art keywords
antioxidants
treatment
skin diseases
inflammatory skin
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38271/99A
Other languages
English (en)
Inventor
Stefan Glombitza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AG
Original Assignee
Hexal AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal AG filed Critical Hexal AG
Publication of AU3827199A publication Critical patent/AU3827199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
AU38271/99A 1998-05-04 1999-05-04 Use of antioxidants for the treatment of inflammatory skin diseases Abandoned AU3827199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1998119616 DE19819616A1 (de) 1998-05-04 1998-05-04 Verwendung von Antioxidantien zur Behandlung von entzündlichen Hauterkrankungen
DE19819616 1998-05-04
PCT/EP1999/003040 WO1999056735A2 (de) 1998-05-04 1999-05-04 Verwendung von antioxidantien zur behandlung von entzündlichen hauterkrankungen

Publications (1)

Publication Number Publication Date
AU3827199A true AU3827199A (en) 1999-11-23

Family

ID=7866467

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38271/99A Abandoned AU3827199A (en) 1998-05-04 1999-05-04 Use of antioxidants for the treatment of inflammatory skin diseases

Country Status (3)

Country Link
AU (1) AU3827199A (de)
DE (1) DE19819616A1 (de)
WO (1) WO1999056735A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2363792C (en) 1999-02-19 2009-10-27 Takeda Chemical Industries, Ltd. Percutaneous absorption preparation of compound having angiotensin ii antagonistic activity
AT514764A1 (de) 2013-09-02 2015-03-15 Sanochemia Ag Beta-Carotin Zubereitung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4242876C2 (de) * 1992-12-18 1997-11-27 Beiersdorf Ag Kosmetische und/oder dermatologische Zubereitungen zur kosmetischen und/oder dermatologischen Pflege der Haut und/oder der Hautanhangsgebilde
CA2164955A1 (en) * 1993-06-18 1995-01-05 Richard J. Sharpe Method for treating hyperkeratosis and diseases mediated by proteases
US5637616A (en) * 1993-06-18 1997-06-10 Arcturus Pharmaceutical Corporation Method for treating diseases mediated by proteases
ES2114817B1 (es) * 1996-05-16 1999-02-16 Zambon S A Asociacion farmacologica entre n-acetilcisteina y levulosa para la prevencion de la muerte celular y enfermedades asociadas.
DE19747546A1 (de) * 1997-10-07 1999-04-08 Thomas Dr Med Zollner Systematische Verabreichung von wasserlöslichen und/oder lipidlöslichen Antioxidantien bei der Behandlung und Prävention von entzündlichen Dermatosen

Also Published As

Publication number Publication date
DE19819616A1 (de) 1999-11-11
WO1999056735A3 (de) 1999-12-29
WO1999056735A2 (de) 1999-11-11

Similar Documents

Publication Publication Date Title
AU3673499A (en) Hydrogel for the therapeutic treatment of aneurysms
PL348059A1 (en) Compounds useful in the treatment of inflammatory diseases
AU7132998A (en) Substituted pyrrolopyridines useful in the treatment of inflammatory diseases
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
AU1773600A (en) Topical treatment of skin disease
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
HUP0104963A3 (en) Compositions for the treatment of skin diseases
AU5056099A (en) Compounds for use in the treatment of inflammation
AUPQ201499A0 (en) Treatment of inflammatory and malignant diseases
AU5729099A (en) Use of cyclopentabenzofuran-derivatives for combating nf-KappaB-dependent diseases
AU7106300A (en) Treatment of skin disorders
AU9278598A (en) Use of azole derivatives for the treatment of inflammatory skin conditions
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
AU4215499A (en) Treatment of neurodegenerative diseases
AU3827199A (en) Use of antioxidants for the treatment of inflammatory skin diseases
AU2509801A (en) Method for the cosmetic treatment of human skin
AU1022501A (en) Use of compositions for the caring treatment of the skin
AU1405001A (en) Treatment of diseases
AU8049098A (en) Composition and methods for the treatment of inflammatory diseases
AU5854799A (en) Novel treatment of neurodegenerative diseases
IL119990A0 (en) Topical compositions for the treatment of skin diseases
AU5759500A (en) Methods for ameliorating icthyosiform skin diseases
AU2001274446A1 (en) Vip-related peptides for the treatment of skin disorders
AU2002350513A1 (en) Use of solasonine for the treatment of skin tumors
AU2908501A (en) Combination therapy for the treatment of inflammatory and respiratory diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase